TT-038

N/A

Report date: 2023/09/20 09:18:31

Base Information

Drug NameTT-038
Drug Alias NameTT-038
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP4 receptor antagonists
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTeon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A